DA-4505
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DA-4505, covering 2025-02-12 to 2025-02-12. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of DA-4505 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Locally Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]